Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
With Ben Johnson off to be the head coach of the Chicago Bears, the Lions will need a new voice to lead the offense. Johnson's move to the division rival has frustrated some fans, and left pundits ...
Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.
8hon MSN
The move was intended in part to prevent the release of sexually explicit texts that lawmakers sent Cassidy Hutchinson.
JOHNSON COUNTY, Tenn. (WCYB) — Update: The suspect arrested in Elizabethton following a shooting in Johnson County has been ...
16h
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback